Breast Cancer Clinical Trial
Official title:
"Ultrasound Based Localization of Lumpectomy Bed in Anatomical Coordinate System" (J-0728)
This is a pilot study. The main purposes for doing the study are to see if there is a relationship between lumpectomy volume and position as measured by USEI and by CT. This is not a study to see if the use of USEI is better than the current method of using CT for daily radiation therapy positioning.
1. Abstract The feasibility, toxicity and efficacy of Partial Brest Irradiation (PBI) are
currently being studied by major cooperative groups such as the NSABP, and RTOG as well as
by several major academic institutions. PBI entails definitive radiation to the lumpectomy
site while minimizing radiation to the remaining breast tissue. The success of PBI is
dependent in no small part to proper target localization. In radiation therapy, to treat an
internal structure, external landmarks must be used to calculate the position of the
internal target. These external landmarks can easily change in a non-rigid structure (e.g.
breast), which would nullify their use as a reference. To address this problem, there have
been recent advances in the application of ultrasound (US) technology in target localization
especially with respect to the prostate. Transcutaneous tracked US emerged as the most
suitable non-invasive daily prostate localization tool. In this procedure an US probe is
tracked and spatially registered with respect to the treatment machine, linear accelerator.
Thus if one localizes the target anatomy in the US images, then the position of the target
is automatically known with respect to the linear accelerator, so that the accelerator can
be correctly aimed.
Unfortunately, contemporary US imaging is not sufficiently sensitive to delineate the
lumpectomy bed for PBI. We propose to supplant B-mode imaging with a novel US elasticity
imaging (USEI) method to delineate the subtle and complex boundaries of the lumpectomy
cavity. Our preliminary studies suggest that USEI may be superior to B-mode imaging (see
statistical section and Ref. 6-7). However our work was only done in ex-vivo tissue models.
In the literature, there are many studies showing the superior sensitivity and specificity
of strain imaging compared to regular B-mode imaging7.
The benefit of developing a way to use ultrasound for target localization is clear.
Identification of the target would no longer be dependent on unreliable external landmarks
but now on direct internal information. As a consequence, targeting errors, most commonly
associated with patient positioning, could be significantly reduced or practically
eliminated. Thus, we propose to study the ability of USEI to detect and characterize the
lumpectomy bed in-vivo using CT data as ground truth. We will pursue our work in two
specific aims:
Aim 1: Describe the concordance between the lumpectomy bed's center-of-mass (COM) as
determined by USEI and CT.
Aim 2: Describe the concordance between the lumpectomy bed volume as measured by USEI and
CT.
;
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |